Hyasen Biotech closes Genética 2026 with Latin America outreach

Hyasen Biotech says it had a productive showing at Genética 2026, the 71st Brazilian Congress of Genetics, in Florianópolis, where the company met researchers, distributors and potential partners from across Brazil and Latin America. The event gave the biotech company a face-to-face platform to discuss its molecular biology portfolio and possible distribution and OEM/ODM opportunities.

Why it matters: - Genética 2026 brought together genetics and genomics researchers from Brazil and across Latin America, making it a key venue for Hyasen Biotech to reach scientific buyers and potential regional partners. - The congress also created direct access to companies and institutions evaluating molecular biology suppliers, which can affect future distribution, manufacturing and product development relationships.

What happened: - Genética 2026, the 71st Brazilian Congress of Genetics, concluded Oct. 2 in Florianópolis, Santa Catarina. - The congress ran from Sept. 29 to Oct. 2 under the theme “One Century of the Gene: From Theory to Genomics.” - Hyasen Biotech staffed Booth 10 and met researchers, distributors and industry partners during the event.

The details: - Hyasen Biotech presented molecular biology solutions covering the full workflow from sample preparation to genomic analysis. - The portfolio included nucleic acid extraction and purification products such as Proteinase K, DNase I and magnetic microspheres. - The company also highlighted PCR and RT-PCR reagents, including polymerases, reverse transcriptases and premixes. - Hyasen Biotech featured qPCR and RT-qPCR reagents designed for sensitivity and workflow flexibility. - The booth also covered LAMP and RT-LAMP enzymes and master mixes. - The company showed NGS library preparation reagents for DNA and RNA sequencing workflows. - Molecular biology enzymes and reagents for diagnostics, genomic research and industrial applications were also part of the display. - Booth conversations included technical questions about enzyme performance and protocol compatibility. - Discussions also touched on distribution and OEM/ODM partnership opportunities for regional product lines. - Genética 2026 featured research areas including human genetics, animal genetics, plant genetics, microbial genetics, bioinformatics and biotechnology. - Visitors included academic researchers exploring extraction workflows and diagnostic manufacturers assessing enzyme suppliers for their kits.

Between the lines: - Hyasen Biotech is signaling interest in Latin American channel-building, not just one-off trade show visibility. - The mix of scientific and commercial visitors suggests the company is targeting both research labs and manufacturers that may embed Hyasen products into their own offerings.

What's next: - Hyasen Biotech says it is open to follow-up discussions on product applications, technical requirements and collaborations. - The company invited attendees and prospective partners to continue the conversation by email at hyasen@hyasen.com or through its website, the company’s website. - The company said it looks forward to continuing outreach in Brazil and beyond.